A Comparison of Three Anti-HIV Drug Combinations in HIV-Infected Patients

NCT00005106 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

230

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Lamivudine/Zidovudine
DRUG: Abacavir sulfate
DRUG: Nelfinavir mesylate
DRUG: Lamivudine
DRUG: Stavudine

Sponsor

Glaxo Wellcome